Table 2.
Relationship of duration between COVID-19 diagnosis and delivery with the detection of SARS-CoV-2 RNA and IgG-anti-SARS-CoV-2 antibodies in the cord blood samples
| Mothers | Infants | |||
|---|---|---|---|---|
| Duration between viral RNA detection and delivery (No. of days)a | No. of SARS-CoV-2 RNA positives | SARS-CoV-2 RNA No. positive/No. tested (%) |
IgG-anti-SARS-CoV-2 antibodies No. positive/no. tested (%) |
|
| Nasopharyngeal swab | Cord blood | |||
| 0–3 | 36 | 0/36 | 1/34 (2.9) | 8/34 (23.5) |
| 4–7 | 11 | 0/10 | 0/8 | 1/8 |
| 8–14 | 06 | 1/6 | 0/6 | 0/6 |
| 15–21 | 04 | 0/4 | 0/3 | 2/3 |
| Total | 57 | 1/56 (1.8) | 1/51 (1.9) | 11/51 (21.6) |
| RNA negative at delivery (controls) | 0 | Not tested | 0/39 | 20/39 (51.3) |
aIn addition, 2 neonates born to mothers with COVID-19 60 days before delivery were positive in IgG ELISA and PRNT